Retina Synthesis
Episodes
The Port Delivery Stem for Treatment of Neovascular AMD
14 Apr 2026
Contributed by Lukas
In this episode we discuss the impressive Phase 4 results of the Belvedere Trial for treatment of neovascular AMD with Dr. Michael Klufas of Wills Eye...
Jayakrishna Ambati
07 Apr 2026
Contributed by Lukas
In our latest episode with the discuss the promising results of a Phase I clinical trial looking at kamuvidine 8 an inflammasome inhibitor in the trea...
Treatment of Proliferative Diabetic Retinopathy After Protocol S
31 Mar 2026
Contributed by Lukas
In this episode, we discuss real world treatment of proliferative diabetic retinopathy using data from the Vestrum data base; with Dr. Adrienne Scott,...
Encapsulated Cell Therapy for MacTel2
24 Mar 2026
Contributed by Lukas
In this episode, we discuss the pathbreaking use of an encapsulated cell therapy that produces CNTF for the successful treatment of MacTel with Roger ...
Teleretinology - Update on Screening and Artificial Intelligence
17 Mar 2026
Contributed by Lukas
In our latest update, we discuss strategies for developing a teleretinology network with Dr. Glenn Yiu, Professor of Ophthalmology, University of Cali...
Untitled Episode
12 Mar 2026
Contributed by Lukas
In our latest update we discuss the prevention and treatment of endophthalmitis with one of the world's leading authorities, Dr. Harry Flynn , ho...
Ophthalmic Artery Angioplasty for Geographic Atrophy
03 Mar 2026
Contributed by Lukas
We discuss early studies of ophthalmic artery angioplasty in cases of advanced geographic atrophy with Dr. Philip Rosenfeld of the Bascom Palmer Eye I...
The PRIMA Retinal Implant for Geographic Atrophy
24 Feb 2026
Contributed by Lukas
In our latest episode, we discuss the results of the PRIMA retinal implant in treating eyes with center involved geographic atrophy as presented in a ...
The New Day Trial of Iluvien for DME
17 Feb 2026
Contributed by Lukas
In this episode, In our latest episode,  we discuss the results of a randomized trial comparing the Iluvien sustained release steroid implant to afl...
Photodynamic Therapy of Central Serous Chorioretinopathy
10 Feb 2026
Contributed by Lukas
We discuss the diagnosis and management of central serous chorioretinopathy with photodynamic therapy with Dr. Andrew Lotery, Professor of Ophthalmolo...
Cooling Anesthesia for Intravitreal Injection
04 Feb 2026
Contributed by Lukas
In this episode, we discuss the use of low dose cryogenic application for anesthesia prior to intravitreal injection with Dr. Michael Singer, Adjunct ...
New Developments in Treating ROP
27 Jan 2026
Contributed by Lukas
In our latest update, we discuss current treatment of retinopathy of prematurity as well as new developments in disease prevention with Dr. Darius Mos...
TKI Drugs in the Treatment of nAMD and DME
20 Jan 2026
Contributed by Lukas
In this update, we review the TKI program of Eyepoint Pharmaceuticals with Dr. Jay Duker, President and CEO.
Artificial Intelligence and Home OCT for nAMD
13 Jan 2026
Contributed by Lukas
We discuss a study that showed that an artificial intelligence powered system can detect clinically significant fluid as well as experienced observers...
Undertreatment of Diabetic Macular Edema: A Clinical Challenge
06 Jan 2026
Contributed by Lukas
We discuss studies documenting the undertreatment of diabetic macular edema and possible strategies for alleviating it with Dr. Matthew Starr, Assista...
Suprachoroidal Gene Therapy for Nonproliferative Diabetic Retinopathy
19 Dec 2025
Contributed by Lukas
In this episode, we discuss promising results of gene therapy, administered suprachoroidally, for the treatment of nonproliferation diabetic retinopat...
Optogenetics for Treating Inherited Retinal Degenerations
11 Dec 2025
Contributed by Lukas
We discuss promising Phase 2 results from Nanoscope regarding the use of optogenetics for treatment of retinal degenerations with Allen Ho, MD, Profes...
Untitled EpisodeArtificial Intelligence in the Management of Macular Disease
03 Dec 2025
Contributed by Lukas
We discuss the early results of the use of artificial intelligence in the management of macular disorders with Dr. Pearse Keane, the world's firs...
Stem Cell Therapy for Geographic Atrophy
19 Nov 2025
Contributed by Lukas
We discuss with Dr. Rajesh C. Rao, Leonard Miller Professor of Ophthalmology, Kellogg Eye Center, University of Michigan, the results of a Phase I tri...
Intravitreal Gene Therapy for Neovascular AMD
13 Nov 2025
Contributed by Lukas
We discuss the early results of gene therapy of neovascular AMD by intravitreal administration of the vector with Dr. Glenn Yiu, Professor of Ophtha...
The TRUCKEE Study of Faricimab for Neovascular AMD
05 Nov 2025
Contributed by Lukas
We discuss the long term results of the Truckee Study, a stage 4 clinical trial in the treatment of neovascular AMD with faricimab with Dr. Arshad Kha...
The VERONA Trial of a TKI for the Treatment of DME
29 Oct 2025
Contributed by Lukas
We discuss the use of a tyrosinase kinase inhibitor, EY-1901, for the treatment of diabetic macular edema with Dr. Yasha Modi, New York University, an...
Photobiomodulation for the Treatment of Dry AMD
24 Oct 2025
Contributed by Lukas
We discuss early results from the study of photobiomodulation for the treatment of dry AMD with Dr. David Boyer, Adjunct Professor of Clinical Ophthal...
8 mg Aflibercept in Diabetic Macular Edema
08 Oct 2025
Contributed by Lukas
We review long term results from the PHOTON Study with Eric Schneider, MD, Tennessee Retina, Nashville, TM.
Subretinal Gene Therapy for Neovascular AMD
03 Oct 2025
Contributed by Lukas
We review the latest results from the Regenexbio sub retinal gene therapy program with Robert Avery MD, California Retina Consultants, Santa Barbara, ...
Does Pegcetacoplan Treatment Affect Dry Macular Degeneration?
25 Sep 2025
Contributed by Lukas
We discuss whether pegcetacoplan therapy of geography atrophy affects the progression of dry AMD with Paul Hahn MD PhD of PH Retina, Nanuet, New York.
Rapid Fluid Resolution with Aflibercept 8mg may be Associated with Extended Dosing Intervals in nAMD
08 Sep 2025
Contributed by Lukas
We discuss the observation that resolution of retinal fluid at one month in eyes with nAMD treated with aflibercept 8mg may herald longer duration tre...
The Good Days Dilemma - Support for Patient Co-Payments in Retinal Pharmacotherapy
28 Aug 2025
Contributed by Lukas
We discuss the current state of the Good Days charitable foundation with Dr. Michael Lai, MD. PhD, Retina Group of Washington, Assistant Clinical Prof...
Immediate vs Delayed Treatment of GA with Pegcetacoplan
19 Aug 2025
Contributed by Lukas
We discuss the long term results of the Oaks, Derby, and GALE studies looking at the benefit of early treatment of geographic atrophy in AMD with Dr. ...
Eyes with both Geographic Atrophy and Neovascular AMD: An IRIS Study
12 Jul 2024
Contributed by Lukas
We discuss management of eyes with both geographic atrophy and neovascular AMD with Dr. Ted Leng of the Byers Eye Institute, Stanford University Schoo...
The Davio 2 Trial for Neovascular AMD
31 May 2024
Contributed by Lukas
We review the 6 month results of the Davio 2 trial of the Durayvu TKI delivery system for maintenance therapy of neovascular AMD with Dr. Carl Regil...
The GALE Extension Study
17 May 2024
Contributed by Lukas
We discuss the latest promising results from the GALE extension study of pegcetacoplan with Dr. Ashkan Abbey of Texas Retina Associates
AXPAXLI for Diabetic Retinopathy
09 May 2024
Contributed by Lukas
We discuss the promising phase I results of the Helios trial studying AXPAXLIÂ TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot ...
NSAIDS in the treatment of Central Serous Chorioretinopathy
18 Apr 2024
Contributed by Lukas
We discuss the use of non steroidal inflammatory agents in the management of central serous chorioretinopathy with Dr. Michael Singer of San Antonio...
EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD
04 Apr 2024
Contributed by Lukas
We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascula...
Intravitreal Gene Therapy for neovascular AMD with 4D-150
28 Mar 2024
Contributed by Lukas
We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the Univ...
KSI 501 Bispecific Anti-VEGF Biopolymer Treatment of DME
21 Mar 2024
Contributed by Lukas
We discuss the use of a novel bispecific anti-VEGF Anti IL-6 Antibody Biopolymar Conjugate for the treatment of DME with Dr. Mark R. Barakat of Phoeni...
Retinal Vasculitis Following Pegcetcoplan Therapy of Geographic Atrophy
14 Mar 2024
Contributed by Lukas
We discuss the occurrence of retinal vasculitis following pegcetcoplan therapy of geographic atrophy with Dr. Andrew Witkin of the New England Eye Cen...
High Dose Aflibercept in Severe Diabetic Macular Edema
07 Mar 2024
Contributed by Lukas
We discuss the treatment results of high dose aflibercept in the eyes in the most severe quartile of diabetic macular edema with Dr. Roger Goldberg of...
IL-6 Inhibition in the Treatment of Uveitis Macular Edema
29 Feb 2024
Contributed by Lukas
We discuss the use of an IL-6 inhibitor in the treatment of uveitis macular edema with Dr. Sumit Sharma of the Cole Eye Institute, Cleveland Clinic.
The High Dose Aflibercept DME Trial
22 Feb 2024
Contributed by Lukas
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. ...
The Annexon Geographic Atrophy Trial
15 Feb 2024
Contributed by Lukas
We discuss the unique results of the Annexon geographic atrophy Phase I clinical trial with Dr. Roger Goldberg of Bay Area Retina Associates, Walnut C...
Diagnostics for Retinoblastoma
08 Feb 2024
Contributed by Lukas
We review the latest diagnostic and therapeutic approaches for retinoblastoma with Dr. Jesse Berry, Associate Professor of Ophthalmology, Children&apo...
A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD
01 Feb 2024
Contributed by Lukas
We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinde...
Visual Outcomes in the Davio Trial Looking at TKI EY-1901
25 Jan 2024
Contributed by Lukas
We discuss the characteristics of eyes with the best visual outcomes in the Davio trial of TKI EY-1901 with Dr. Philip Storey of the Austin Retina Ass...
A Post-Hoc Comparison of Syfovre and Izervay in Treatment of Geographic Atrophy
18 Jan 2024
Contributed by Lukas
We discuss a post-hoc study comparing the efficacy of Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) with Paul Hahn, MD, PhD, of NJ Retina.
4 Year Results from DRCR Network Protocol W
11 Jan 2024
Contributed by Lukas
We discuss a comparative trial of preventive therapy for non-proliferative retinopathy vs. ad hoc treatment of disease complications with Dr. Hani Sal...
Gene Therapy for X-Linked Retinitis Pigmentosa
04 Jan 2024
Contributed by Lukas
We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of ...
Optogenetic Therapy of Inherited Retinal Degenerations
21 Dec 2023
Contributed by Lukas
We discuss the use of optogenetics for the treatment of inherited retinal degenerations with Dr. Jose Sahel, Chairman and Distinguished Professor of O...
A Real World Analysis of Aflibercept Therapy of Diabetic Macular Edema
14 Dec 2023
Contributed by Lukas
We discuss the importance of intensive therapy of DME, when using aflibercept for DME, as suggested by a review of real world cases from the Vestrum ...
Topical Therapy of Diabetic Macular Edema
07 Dec 2023
Contributed by Lukas
We discuss the use of a topical agent for the treatment of diabetic macular edema with Dr. Arshad Khanani, Director of Research, Sierra Eye Associates...
Mitochrondial Therapy of Intermediate AMD
30 Nov 2023
Contributed by Lukas
We review novel approaches for the treatment of intermediate AMD, with Dr. Barry Kuppermann, Director Gavin Herbert Eye Institute, Chairman Department...
Safety Considerations in Retinal Gene Therapy
16 Nov 2023
Contributed by Lukas
 In our latest update, we discuss safety issues associated with retinal gene therapy with Professor Glenn Yiu of the University of California School ...
An Oral Agent for Treatment of Diabetic Retinopathy
09 Nov 2023
Contributed by Lukas
We discuss the use of a novel oral agent for the treatment of diabetic retinopathy with David R. Lally, MD, Director of Research, New England Retina C...
Intravitreal Gene Therapy with 4D-150
26 Oct 2023
Contributed by Lukas
We discuss intravitreal gene therapy with a new agent, 4D-150 with Veeral Sheth, MD, MBAÂ Assistant Clinical Professor of Ophthalmology University of...
Optogenetics in the Treatment of Retinal Degenerations
19 Oct 2023
Contributed by Lukas
We discuss the use of optogenetics in the treatment of retinal degenerations with Dr. Michael Singer, Adjunct Professor of Ophthalmology, University o...
Update on the Iluvien System for Treatment of Diabetic Macular Edema
12 Oct 2023
Contributed by Lukas
We discuss retinal drying in diabetic macular edema using the Iluvien implant with Dr. Michael Singer, Adjunct Professor, University of Texas Health ...
The Ophthea Clinical Trial for Neovascular AMD
05 Oct 2023
Contributed by Lukas
We discuss the use of blockade of VEGF C and D in the treatment of neovascular AMD with Dr. Dante Pieramici, California Retina Research Foundation, Ca...
Senolytic Therapy for Diabetic Macular Edema
28 Sep 2023
Contributed by Lukas
We discuss the use of a novel treatment approach, senolytic therapy, for the treatment of diabetic macular edema with Dr. David Boyer, Adjunct Profess...
The Port Delivery System for Treating Diabetic Retinopathy
21 Sep 2023
Contributed by Lukas
We discuss the use of the PDS in the treatment of diabetic retinopathy and diabetic macular edema with Professor Carl Regillo of the Wills Eye Hospita...
A Profile of Eugene de Juan, MD
14 Sep 2023
Contributed by Lukas
Dr. Eugene de Juan, winner of this year's ASRS Pyron Award, joins us to discuss his career highlights. Dr. de Juan is CEO of Forsight Labs and Pr...
An Implantation Telescope for Macular Disease
31 Aug 2023
Contributed by Lukas
We discuss the use of an improved implantable telescope as a low vision aid in patients with macular disease with Dr. David Almeida, Erie Retina Resea...
Prevention of Vision Loss in the Gather Trial of IZERVAY
24 Aug 2023
Contributed by Lukas
We discuss the prevention of vision loss in the Gather 2 trial of IZERVAY with Dr. Carl Danzig of the Rand Eye Institute, Pompano Beach, Florida
GALE Long Term Extension Study for GA
14 Aug 2023
Contributed by Lukas
We discuss a 30-Month Outcome with Pegcetacoplan for the Treatment of Geographic Atrophy with Nathan Steinle MD, California Retina Consultants, Santa ...
Pegcetacoplan (SYFOVRE) Clinical Update
11 Aug 2023
Contributed by Lukas
We discuss the latest information on Safety & Efficacy in Clinic and Clinical Trials with Cedric Francois, MD, PhD.
Faricimab in Neovascular AMD
03 Aug 2023
Contributed by Lukas
We discuss the latest information on the use of faricimab in neovascular AMD with Dr. Yasha Modi, Associate Professor of Ophthalmology, NYU Langone Me...
High Dose Aflibercept for Neovascular AMD
27 Jul 2023
Contributed by Lukas
We discuss the use of high dose aflibercept for the treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor, Roski Eye Institute ...
Pegcetacoplan for Geographic Atrophy Update
20 Jul 2023
Contributed by Lukas
We discuss the latest information on the use of pegcetacoplan for geographic atrophy in AMD with Dr. Dilsher Dhoot, California Retinal Consultants.
Ocular Therapeutix: A TKI and Hydrogel Implant
13 Jul 2023
Contributed by Lukas
We discuss the use of a novel drug (tyrosine kinase inhibitor) and novel delivery system (hydrogel) for the treatment of neovascular AMD with Dr. Pete...
Biosimilar Drugs for Retinal Diseases
06 Jul 2023
Contributed by Lukas
We discuss the use of biosimilar drugs for retinal diseases with Dr. Arghavan Almony, author of definitive monograph of these agents.
Faricimab vs Aflibercept in Diabetic Macular Edema
29 Jun 2023
Contributed by Lukas
In our latest update, we discuss the relative drying effects of faricimab and aflibercept in the treatment of diabetic macular edema with Dr. Roger Go...
Artificial Intelligence in the Management of Geographic Atrophy
22 Jun 2023
Contributed by Lukas
In our latest update, we discuss the use of artificial intelligence in the management of geographic atrophy with Professor Pearse Keane, Moorfields Ey...
Molecular Diagnostics in the Diagnosis and Treatment of Uveal Melanoma
15 Jun 2023
Contributed by Lukas
In our latest update, we discuss the use of molecular techniques in the management of uveal melanoma with Dr. William Harbour, Professor and Chair, De...
Faricimab in the Treatment of Retinal Venous Occlusion
08 Jun 2023
Contributed by Lukas
We discuss the results of clinical trials studying the use of faricimab in the treatment of retinal venous occlusion with Dr. Ramin Tadayoni, Profes...
The Use of High Dose Aflibercept in Diabetic Macular Edema
01 Jun 2023
Contributed by Lukas
We review the one year results of a clinical trial using high dose aflibercept (8mg) for the treatment of diabetic macular edema with Dr. David Boyer,...
Widefield OCT Angiography
25 May 2023
Contributed by Lukas
We the discuss the use of wide field OCT angiography in the management of diabetic retinopathy, retinal vein occlusion, and pediatric retinal disease ...
Aflibercept Therapy of Retinopathy of Prematurity
18 May 2023
Contributed by Lukas
We review the use of anti-VEGF therapy for retinopathy of prematurity and in particular, the results of a clinical trial employing aflibercept with Dr...
Home OCT in the Management of Neovascular AMD: Latest Development
11 May 2023
Contributed by Lukas
We discuss the use of home OCT and artificial intelligence in the management of anti-VEGF therapy of neovascular AMD with Dr. Anat Loewenstein, Direct...
Suprachoroidal Corticosteroids for the Treatment of Macular Edema
04 May 2023
Contributed by Lukas
We discuss the use of suprachoroidal triamcinolone for the treatment of macular edema with Dr. Steven Yeh, Truhlsen Chair of Ophthalmology, University...
The Use of the Port Delivery System for the Treatment of Diabetic Macular Edema
27 Apr 2023
Contributed by Lukas
We discuss the use of the port delivery system for the treatment of diabetic macular edema with Dr. Arshad Khanani, Director of Clinical Research, Sie...
Suprachoroidal Therapy of Neovascular AMD
20 Apr 2023
Contributed by Lukas
We discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD with Dr. Mark Ba...
Microperimetry in the Assessment of Geographic Macular Atrophy
13 Apr 2023
Contributed by Lukas
We discuss the use of microperimetry to assess treatment effects of anti-complement therapy (Apellis) of geographic atrophy with Dr. Nadia Waheed, Ass...
Subretinal Gene Therapy for Neovascular AMD
06 Apr 2023
Contributed by Lukas
We discuss the results of the RGX-314 study of subretinal gene therapy for neovascular AMD with Dr. Allen Ho, Professor of Ophthalmology, Wills Eye Ho...
A Tyrosine Kinase Inhibitor Implant for the Treatment of Neovascular AMD
30 Mar 2023
Contributed by Lukas
In our latest update, We discuss the results of a one year Phase I trial exploring the use of a tyrosinase inhibitor in an hydrogel implant for the tr...
15 Year Results of Fixed Dose Anti-VEGF Treatment of Neovascular AMD
23 Mar 2023
Contributed by Lukas
We discuss long term results of fixed dose anti-VEGF therapy for neovascular AMD with Dr. Ivan Suner, Retina Associates of Florida, Tampa, Florida.
Dexamethasone Implant for Treating Diabetic Macular Edema
16 Mar 2023
Contributed by Lukas
We discuss the use of corticosteroids, in particular, the dexamethasone implant in the management of diabetic macular edema with Dr. Kevin Blinder, Pr...
Retinal Vasculitis Update
02 Mar 2023
Contributed by Lukas
Thomas Albini, MD, Professor of Clinical Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute provides a comprehe...
Central Serous Chorioretinopathy
23 Feb 2023
Contributed by Lukas
We discuss the latest developments in diagnostic evaluation and treatment of eyes with central serous chorioretinopathy. with Roger Goldberg, MD, Bay ...
Faricimab Update
16 Feb 2023
Contributed by Lukas
Dr. Roger Goldberg from Bay Area Retina Associates, Walnut Creek, CA discusses the latest data regarding the use of faricimab in diabetic macular edem...
Strategies for Treatment Pauses in Neovascular AMD
02 Feb 2023
Contributed by Lukas
We discuss various strategies for treatment pauses in management of neovascular AMD, differences between bevacizumab and aflibercept in patients who c...
Gene Therapy of Inherited Retinal Diseases
26 Jan 2023
Contributed by Lukas
We review the current status of gene therapy for inherited retinal disorders, discussing preoperative evaluation, surgery, and follow up with Dr. Nine...
Suprachoroidal Tyrosinase Therapy of Neovascular AMD
12 Jan 2023
Contributed by Lukas
We discuss the use of a suprachoroidal delivery system for delivery of tryrosinase kinase inhibitor for the treatment of neovascular AMD with Dr. Thom...
KSI-301 (tarcocimab tedromer) therapy of Retinal Vein Occlusion
05 Jan 2023
Contributed by Lukas
We discuss a phase 2/3 trial employing tarcocimab reformer for branch and central vein occlusion with Michael Singer, MD, Clinical Professor Universit...
The Efficacy of Avacincaptad Pegol in Treatment of Geographic Atrophy: Gather 1 & 2 Study Results
15 Dec 2022
Contributed by Lukas
We discuss the use of intravitreal avacincaptad peg for the treatment of geographic atrophy in two randomized trials, Gather 1 and Gather 2 with Dr....
En Face OCT, Intermediate AMD, and Georgraphic Atrophy
08 Dec 2022
Contributed by Lukas
We discuss the role that en-face optical coherence tomography (OCT) can play in understanding the evolution of intermediate AMD and geographic atrophy...
Safety of Pegcetacoplan in the 24 month Derby and Oaks Studies
01 Dec 2022
Contributed by Lukas
We review the 24 month results of the Derby and Oaks trials, with emphasis on the safety of pegcetcoplan with Caroline Baumal, MD, Professor of Ophtha...
Predominantly Peripheral Lesions on Ultra-Wide field Imaging & Risk of DR Worsening Over Time
17 Nov 2022
Contributed by Lukas
Dr. Dennis Marcus, Clinical Professor of Ophthalmology, Medical College of Georgia at Augusta University discusses the value of ultra wide field imagi...
10 Year Retrospective Review of a PHP Device for Early Detection of Neovascular AMD
10 Nov 2022
Contributed by Lukas
Dr. Michael Elman of Elman Retina Group, Baltimore, Maryland, presents 10 year data demonstrating that Preferential Hyperacuity Perimetry (the Foresee...
Current Therapy for Venous Occlusive Disease and a Clinical Trial Involving Stem Cell Therapy for CRVO
27 Oct 2022
Contributed by Lukas
Dr. Susanna Park reviews current therapy of retinal branch and central vein occlusion and discusses a Phase I trial (the TRUST study) investigating th...
Senolytic Therapy for Diabetic Macular Edema and Neovascular AMD
20 Oct 2022
Contributed by Lukas
We discuss a novel mechanism of action for the treatment of diabetic macular edema and neovascular AMD with Phase I/II trial results Dr. Raj Maturi, M...